Passive tumour targeting of polymer-coated adenovirus for cancer gene therapy.

Adenovirus provides many opportunities as a vector for delivery of cytotoxic genes to tumours. Polymer coating of adenovirus is known to increase its plasma circulation kinetics, affording the possibility of active and passive targeting to tumours. Here we show that polymer-coating adenovirus (pc-vi...

Full description

Bibliographic Details
Main Authors: Fisher, K, Green, N, Hale, A, Subr, V, Ulbrich, K, Seymour, L
Format: Journal article
Language:English
Published: 2007
_version_ 1826305141633974272
author Fisher, K
Green, N
Hale, A
Subr, V
Ulbrich, K
Seymour, L
author_facet Fisher, K
Green, N
Hale, A
Subr, V
Ulbrich, K
Seymour, L
author_sort Fisher, K
collection OXFORD
description Adenovirus provides many opportunities as a vector for delivery of cytotoxic genes to tumours. Polymer coating of adenovirus is known to increase its plasma circulation kinetics, affording the possibility of active and passive targeting to tumours. Here we show that polymer-coating adenovirus (pc-virus) abrogates its normal infectivity in vitro and also in liver following intravenous injection. The coated virus accumulates within solid subcutaneous AB22 mesothelioma tumours 40-times more than unmodified virus, and mediates higher levels of transgene expression within tumours. This is the first demonstration of passive tumour targeting of polymer-coated adenoviruses administered by intravenous injection, and also the first time pc-virus has been shown to be infectious following passive targeting to tumours in vivo. This technology provides an interesting option for delivery of therapeutic viruses to disseminated tumour masses by intravenous injection.
first_indexed 2024-03-07T06:28:22Z
format Journal article
id oxford-uuid:f51b21c4-2c91-459b-81c4-3266998246bc
institution University of Oxford
language English
last_indexed 2024-03-07T06:28:22Z
publishDate 2007
record_format dspace
spelling oxford-uuid:f51b21c4-2c91-459b-81c4-3266998246bc2022-03-27T12:24:52ZPassive tumour targeting of polymer-coated adenovirus for cancer gene therapy.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f51b21c4-2c91-459b-81c4-3266998246bcEnglishSymplectic Elements at Oxford2007Fisher, KGreen, NHale, ASubr, VUlbrich, KSeymour, LAdenovirus provides many opportunities as a vector for delivery of cytotoxic genes to tumours. Polymer coating of adenovirus is known to increase its plasma circulation kinetics, affording the possibility of active and passive targeting to tumours. Here we show that polymer-coating adenovirus (pc-virus) abrogates its normal infectivity in vitro and also in liver following intravenous injection. The coated virus accumulates within solid subcutaneous AB22 mesothelioma tumours 40-times more than unmodified virus, and mediates higher levels of transgene expression within tumours. This is the first demonstration of passive tumour targeting of polymer-coated adenoviruses administered by intravenous injection, and also the first time pc-virus has been shown to be infectious following passive targeting to tumours in vivo. This technology provides an interesting option for delivery of therapeutic viruses to disseminated tumour masses by intravenous injection.
spellingShingle Fisher, K
Green, N
Hale, A
Subr, V
Ulbrich, K
Seymour, L
Passive tumour targeting of polymer-coated adenovirus for cancer gene therapy.
title Passive tumour targeting of polymer-coated adenovirus for cancer gene therapy.
title_full Passive tumour targeting of polymer-coated adenovirus for cancer gene therapy.
title_fullStr Passive tumour targeting of polymer-coated adenovirus for cancer gene therapy.
title_full_unstemmed Passive tumour targeting of polymer-coated adenovirus for cancer gene therapy.
title_short Passive tumour targeting of polymer-coated adenovirus for cancer gene therapy.
title_sort passive tumour targeting of polymer coated adenovirus for cancer gene therapy
work_keys_str_mv AT fisherk passivetumourtargetingofpolymercoatedadenovirusforcancergenetherapy
AT greenn passivetumourtargetingofpolymercoatedadenovirusforcancergenetherapy
AT halea passivetumourtargetingofpolymercoatedadenovirusforcancergenetherapy
AT subrv passivetumourtargetingofpolymercoatedadenovirusforcancergenetherapy
AT ulbrichk passivetumourtargetingofpolymercoatedadenovirusforcancergenetherapy
AT seymourl passivetumourtargetingofpolymercoatedadenovirusforcancergenetherapy